Published in N Engl J Med on March 31, 1977
Gram-negative sepsis: a dilemma of modern medicine. Clin Microbiol Rev (1993) 1.55
Preventing infection in neutropenic cancer patients. West J Med (1983) 1.38
Management of infection in the neutropenic patient. Br Med J (Clin Res Ed) (1986) 1.10
Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunction. Cochrane Database Syst Rev (2015) 0.91
Neutropenia, inflammation, and the kinetics of transfused neutrophils in rabbits. J Clin Invest (1979) 0.87
Pulmonary complications in patients receiving granulocyte transfusions and amphotericin B. Can Med Assoc J (1984) 0.85
Safety and efficacy of activated transfected killer cells for neutropenic fungal infections. J Infect Dis (2010) 0.82
Granulocyte transfusion therapy: randomization after all? Haematologica (2009) 0.81
Luminescent-activated transfected killer cells to monitor leukocyte trafficking during systemic bacterial and fungal infection. J Infect Dis (2011) 0.79
Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction. Cochrane Database Syst Rev (2016) 0.76
New developments in the treatment of gram-negative bacteremia. West J Med (1986) 0.76
Supportive care in patients with acute leukaemia: historical perspectives. Blood Transfus (2014) 0.76
Use of healthy-donor granulocyte transfusions to treat infections in neutropenic patients with myeloid or lymphoid neoplasms: experience in 74 patients treated with 373 granulocyte transfusions. Acta Haematol (2013) 0.76
Infections in acute leukemia: a retrospective study of 148 patients. Korean J Intern Med (1986) 0.75
Remission-induction regimens in acute nonlymphocytic leukemia. West J Med (1980) 0.75
Comparison of the effects of filtration leucapheresis and discontinuous flow centrifugation leucapheresis on granulocyte microbicidal function. J Clin Pathol (1983) 0.75
Advances in the management of adult acute myelogenous leukaemia. Br Med J (1980) 0.75
Management of the febrile neutropenic patient. Can Med Assoc J (1983) 0.75
Granulocytopenia and septicaemia. Br Med J (1980) 0.75
Single-donor granulocyte transfusions for improving the outcome of high-risk pediatric patients with known bacterial and fungal infections undergoing stem cell transplantation: a 10-year single-center experience. Bone Marrow Transplant (2015) 0.75
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet (2010) 11.55
Hematologic malignancies and other marrow failure states: progress in the management of complicating infections. Semin Hematol (1974) 2.89
Leukapheresis by continuous flow centrifugation (CFC) in patients with chronic myelocytic leukemia (CML). Blood (1969) 2.71
Amphotericin B-resistant yeast infection in severely immunocompromised patients. Am J Med (1988) 2.44
Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease. Proc Natl Acad Sci U S A (1988) 2.42
Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. Cancer Res (1998) 2.33
Cellular interactions in the proliferative response of human T and B lymphocytes to phytomitogens and allogeneic lymphocytes. J Exp Med (1974) 2.27
Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. Blood (1993) 2.12
Stimulatory capacity of human T and B lymphocytes in the mixed leukocyte culture. Nature (1974) 2.09
Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11. Cancer Res (1996) 1.99
Management of infections in patients with leukemia and lymphoma: current concepts and experimental approaches. Semin Hematol (1972) 1.78
Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers? Blood (1992) 1.77
Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations. Cancer Res (1994) 1.54
Interferon-alpha-associated focal segmental glomerulosclerosis with massive proteinuria in patients with chronic myeloid leukemia following high dose chemotherapy. Cancer (1998) 1.52
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer. JAMA (1999) 1.49
Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia. Blood (1996) 1.49
High-dose cytosine arabinoside therapy for refractory leukemia. Blood (1983) 1.44
Lipid management: maximising reduction of cardiac risk. Clin Med (2013) 1.42
High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and results. J Clin Oncol (1989) 1.41
Normal granulocyte transfusion therapy: treatment of septicemia due to gram-negative bacteria. N Engl J Med (1972) 1.41
Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. J Clin Oncol (2000) 1.36
Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes. J Clin Invest (1978) 1.31
Stimulated lymphocyte cultures: responder recruitment and cell cycle kinetics. J Exp Med (1974) 1.29
Long-term second remissions in acute lymphatic leukemia. Cancer (1975) 1.27
Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant (1991) 1.27
Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia. Bone Marrow Transplant (1998) 1.25
Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease. J Clin Oncol (1996) 1.22
T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood (2000) 1.19
A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia. N Engl J Med (1981) 1.17
Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease. J Clin Oncol (1991) 1.16
Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR). Bone Marrow Transplant (2001) 1.16
The association of ulceration of the foot with cardiovascular and all-cause mortality in patients with diabetes: a meta-analysis. Diabetologia (2012) 1.10
Studies on a procoagulant fraction of southern copperhead snake venom: the preferential release of fibrinopeptide B. J Lab Clin Med (1970) 1.10
Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma. Blood (1978) 1.07
Toxic epidermal necrolysis in a patient with graft-vs-host reaction. Arch Dermatol (1972) 1.07
Graft-versus-host disease. Morphologic variation and differential diagnosis in 8 cases of HL-A matched bone marrow transplantation. Am J Pathol (1971) 1.06
Allogeneic bone-marrow transplantation for chronic myelogenous leukaemia. Lancet (1984) 1.06
Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group. Bone Marrow Transplant (2000) 1.05
Transmission of toxoplasmosis by leukocyte transfusion. Blood (1971) 1.04
Computer-assisted audits of blood component transfusion. Cleve Clin J Med (1989) 1.03
Leukocyte and platelet collection from normal donors with the continuous flow blood cell separator. Transfusion (1971) 1.02
Cardiac pathologic findings in patients treated with bone marrow transplantation. Hum Pathol (1976) 1.01
Graft-versus-host reaction complicating HL-A matched bone-marrow transplantation. Lancet (1970) 1.01
Leukocyte transfusions: role of leukocyte alloantibodies in determining transfusion response. Transfusion (1971) 1.01
Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood (1992) 1.00
Metastatic squamous cell carcinoma of the skin. J Natl Med Assoc (1980) 0.98
Granulocyte transfusion therapy of experimental Pseudomonas pneumonia. J Clin Invest (1974) 0.97
Bacteremias and fungemias in oncologic patients with central venous catheters: changing spectrum of infection. Arch Intern Med (1982) 0.97
Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II study. Cancer (1983) 0.97
High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy. Blood (1990) 0.97
Intensive 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma. J Clin Oncol (1986) 0.95
High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant Group. Leuk Lymphoma (1996) 0.95
Treatment of chronic mucocutaneous moniliasis by immunologic reconstitution. Clin Exp Immunol (1971) 0.94
HL-A and mixed leukocyte culture matched allogeneic bone marrow transplantation in patients with acute leukemia. Transplant Proc (1971) 0.93
Veno-occlusive disease of the liver after allogeneic bone marrow transplantation: possible association with graft-versus-host disease. Ann Intern Med (1979) 0.93
Second HLA-identical sibling transplants for leukemia recurrence. Bone Marrow Transplant (1992) 0.93
Central nervous system toxicity of high-dose systemic cytosine arabinoside. Cancer (1981) 0.93
Study of cell dose and storage time on engraftment of cryopreserved autologous bone marrow in a canine model. Transplantation (1978) 0.92
Experimental Pseudomonas pneumonia in leukopenic dogs: comparison of therapy with antibiotics and granulocyte transfusions. Blood (1976) 0.92
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update. Semin Oncol (1987) 0.92
Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer. J Clin Oncol (1983) 0.91
Granulocyte collection by continuous-flow filtration leukapheresis. Blood (1972) 0.91
Acute lethal carditis caused by high-dose combination chemotherapy. A unique clinical and pathological entity. Lancet (1976) 0.91
Transplantation of allogenic bone marrow in canine cyclic neutropenia. Science (1974) 0.89
Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrow. N Engl J Med (1984) 0.89
Migration of transfused granulocytes in leukopenic dogs. Blood (1977) 0.89
Thrombosis of the aorta caused by mucormycosis. South Med J (1988) 0.89
Burkitt's lymphoma--a model for intensive chemotherapy. Semin Oncol (1977) 0.89
Topical corticosteroid therapy for corneal toxicity from systemically administered cytarabine. Am J Ophthalmol (1982) 0.88
Bone marrow transplantation in patients with leukemia. Incidence and severity of graft-versus-host disease in successful HL-A-matched transplants. Transplantation (1971) 0.88
Coronary spasm in acute myocardial infarction. Heart (1998) 0.88
Complication of bone-marrow transplantation. Graft-versus-host disease resulting from chronic-myelogenous-leukaemia leucocyte transfusions. Lancet (1970) 0.87
Correction of poor platelet transfusion responses with leukocyte-poor HL-A-matched platelet concentrates. Blood (1975) 0.87
Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia. Bone Marrow Transplant (1996) 0.87
A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation. Blood (1998) 0.87
Psoas abscess localization by gallium scan in aplastic anemia. JAMA (1975) 0.86